Rituximab for people with multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 127 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Thách thức trong chẩn đoán và điều trị xơ cứng rải rác khởi phát rất muộn: ca lâm sàng

Article (April 2024)

Anti-CD20 antibodies in relapsing multiple sclerosis: Protocol for a systematic review and network meta-analysis

Preprint in medRxiv (January 2024)

Rituximab is the way forward for managing Multiple Sclerosis (MS) in Sri Lanka

Article in Sri Lanka Journal of Neurology (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.